Medipost Co (XKRX:078160) Ending Cash Position : ₩37,524 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Medipost Co Ending Cash Position?

Medipost Co's Ending Cash Position for the quarter that ended in Dec. 2023 was ₩37,524 Mil.

Medipost Co's quarterly Ending Cash Position declined from Jun. 2023 (₩74,280 Mil) to Sep. 2023 (₩56,949 Mil) and declined from Sep. 2023 (₩56,949 Mil) to Dec. 2023 (₩37,524 Mil).

Medipost Co's annual Ending Cash Position increased from Dec. 2021 (₩10,788 Mil) to Dec. 2022 (₩14,856 Mil) and increased from Dec. 2022 (₩14,856 Mil) to Dec. 2023 (₩37,524 Mil).

Medipost Co Ending Cash Position Historical Data

The historical data trend for Medipost Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co Ending Cash Position Chart

Medipost Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

11,921.88

9,287.90

10,788.50

14,856.38

37,523.52

Medipost Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															14,856.38	32,846.15	74,280.22	56,949.43	37,523.52

Medipost Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Medipost Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	14856.382	+	22667.142
	=	37,524

Medipost Co's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	56949.433	+	-19425.909
	=	37,524

Medipost Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Medipost Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipost Co (XKRX:078160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR

Website

http://www.medi-post.co.kr

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (XKRX:078160) Headlines

No Headlines